The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted the public about a revalidated batch of SMA Gold First Infant Milk Formula (900 grams) being sold in Kaduna State.
NAFDAC made this known via a statement on Sunday, February 22, 2026, saying the product was found with altered expiry dates and linked to infant gastrointestinal distress in a four-month-old infant following consumption.
The agency disclosed that the four‑month‑old infant’s diarrhoea case points to possible product deterioration, risking acute gastroenteritis, dehydration, and electrolyte imbalance in infants.
Others are malnutrition due to compromised nutritional content, secondary infections in immunocompromised infants and fatal outcomes in severe cases if contaminated with pathogenic bacteria.
The agency said the manufacturing and expiry date on the top preprinted sticker was inconsistent with the underlying, originally printed version which confirmed the suspicion of revalidation and tampering.
NAFDAC said the integrity of the product is dependent on compliance with regulatory requirements, noting that any alteration or extension of the shelf life without regulatory approval poses significant risks to public health.
The agency wrote on X: “NAFDAC is alerting healthcare providers, caregivers, and the public to a report of a suspected revalidated SMA Gold First Infant Milk Formula (900g) found for sale in Kaduna State, Nigeria. The product allegedly caused gastrointestinal distress in a 4-month-old infant following consumption.
“Physical examination of the complaint product sample revealed clear indicators of date marking alteration. The manufacturing and expiry date on the top preprinted sticker was inconsistent with the underlying, originally printed version. This confirms the suspicion of revalidation and tampering.
NAFDAC recovers N3bn fake cosmetics at Lagos warehouse
“SMA Gold Infant Formula is a nutritionally complete, whey-dominant formula designed to mirror the nutritional profile of breast milk for babies from birth to 6 months.
“The integrity of the product is dependent on compliance with regulatory requirements. Any alteration or extension of the shelf life without regulatory approval poses significant risks to public health.”
The agency urged distributors, retailers, healthcare professionals, and caregivers to exercise caution and vigilance within the supply chain to avoid the distribution, sale, and use of the product.
It also advised that all packaged food and medical products should be obtained from authorised suppliers while the authenticity and physical condition should be carefully checked.
Credit: The Star
